Friday, May 20, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Sex-specific differences in T-cell responses to COVID-19

by Medical Finance
in Coronavirus
Study: Functional analyses and single cell immunoprofiling uncover sex-specific differences in SARS-CoV2 immune memory development. Image Credit: Imilian / Shutterstock.com
9
SHARES
101
VIEWS
Share on FacebookShare on Twitter

Scientists across the world have worked at an unprecedented rate to characterize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of the coronavirus disease 2019 (COVID-19) pandemic. To this end, several vaccines and therapeutics have been developed to protect individuals from SARS-CoV-2, as well as reduce mortality rates due to SARS-CoV-2 infection.

Study: Functional analyses and single cell immunoprofiling uncover sex-specific differences in SARS-CoV2 immune memory development. Image Credit: Imilian / Shutterstock.com

Study: Functional analyses and single-cell immunoprofiling uncover sex-specific differences in SARS-CoV2 immune memory development. Image Credit: Imilian / Shutterstock.com

Background

In-depth immunoprofiling of individuals infected with SARS-CoV-2 has offered better insights into the basic immune response to acute infection. Previous studies have found a correlation between severe SARS-CoV-2 infection and signature cytokine profiles, which include the cytokine storm and cellular compositions. Some studies have also focused on identifying neutralizing antibodies that are generated during COVID-19, as well as on the SARS-CoV-2 epitopes recognized by memory T-cells.

Single-cell sequencing technologies have been widely used to map T- and B-cell receptor (TCR/BCR) sequences and transcriptional profiles. However, the connection between TCRs, epitopes, and T-cell function and their impact on the development of antibody responses, are poorly understood. Thus, the analysis of immune responses of individuals who were naturally exposed to SARS-CoV-2 has provided insights into the development of immune protection against SARS-CoV-2, as well as other novel pathogens.

About the study

In a new study under consideration at a Nature Portfolio Journal and published on the Research Square* preprint server, researchers evaluate both neutralizing activity and T-cell responses in SARS-CoV-2 infected individuals with mild symptoms linked to a single spreading event. A varied production of T-cell cytokines including Th1, Th2, and Th17 cells was observed in response to both the SARS-CoV-2 spike (S) and nucleoprotein (N) proteins.

In the current study, the researchers used an existing cohort of convalescent individuals, which was previously used for another study by the same authors to profile antibody responses. They used this relatively homogenous study cohort, where all samples were collected from convalescent individuals who were at around six to ten weeks post-mild disease to determine neutralizing antibody responses and T-cell memory.

Understanding the sex-related differences in COVID-19 responses

A large range of neutralization activity was not found to be correlated with age and gender. The researchers investigated T-cell responses as the key factor for antibody development and found a large diversity, both in terms of the nature of the response and magnitude.

To this end, interferon γ (IFN-γ) was developed in response to the SARS-CoV-2 S protein and interleukin 2 (IL-2), IL-5, IL-17F, and tumor-necrosis factor α (TNF-α) were produced in response to N peptides. Interestingly, the T-cell response to N was found to be a better predictor of the previous infection as compared to the S protein.

No significant differences were observed in the magnitude of B- and T-cell responses. In contrast, an orchestration of B-T collaboration was observed during the development of neutralizing antibodies.

A strong association was observed between TNF-α responses and neutralizing activity in male participants; however, such a correlation did not appear among female candidates. Several previous studies have revealed that female candidates exhibit higher innate and adaptive immune responses. Additionally, a higher frequency of autoimmune diseases was also observed in females compared to males.

Prior studies have indicated that males are more susceptible to COVID-19 than females. Scientists have proposed many non-exclusive mechanisms such as differences in mucosa-associated invariant T (MAIT) cells and varied kynurenic acid levels to explain gender-based differences in susceptibility to acute SARS-CoV-2 infection.

In the current study, the researchers suggest that differences in type I IFN signaling in male and female candidates could be the main contributing factor for the sex-specific impact of T-cells on neutralizing antibodies. Furthermore, specific TCRs were also associated with this population of cytokine-producing cells.

Although all analyses were carried out on subjects infected with the original SARS-Cov-2 strain, several studies have reported that novel variants are well-recognized by T-cells elicited by a previous strain. The main importance of this study is that it has provided insight into sex-specific differences in the immune responses to natural COVID-19. In addition, the current study findings indicate mechanisms behind the differential immune response based on gender.

Conclusions

The present study identified a sex-specific association between T-cell cytokine production and the development of neutralizing antibody responses. To this end, several genes were found to be upregulated in a sex-specific manner that was associated with COVID-19 responding CD4 + T-cells and the production of type 1 IFN.

Taken together, the researchers believe a deeper understanding of the impact of sex on immunity will help in the development of future COVID-19 vaccines.

*Important notice

Research Square publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

(A) Schematic of the physical changes that take place when an airborne aqueous droplet equilibrates to the surrounding relative humidity. On the left (blue box) the particle is an aqueous homogenous sphere. As the particle equilibrates to a sub-saturated RH, low-solubility solutes can precipitate inclusions within the droplet (yellow box). At a sufficiently low RH, the dominant solute (NaCl) can crystallize causing the particle to effloresce (black box). (B) Schematic of the CELEBS technique. Virus-containing particles are levitated under controlled conditions and then deposited into media which is then plated onto a cell culture. By enumerating the cytopathic effect from that deposition, the amount of virus present can be quantified. (C) Schematic of the CK-EDB technique. Particles generated by the same droplet dispensers used in CELEBS are levitated under controlled conditions in the path of a laser. The physical changes that take place in that particle are studied through analysis of the light scattered by that particle.

Airborne decay of SARS-CoV-2 occurs within minutes

by Medical Finance
May 20, 2022
0

Understanding the factors that influence the airborne survival of viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in...

Study: COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery. Image Credit: alinabuphoto/Shutterstock

The effect of COVID-19 on routine immunizations for vaccine-preventable diseases

by Medical Finance
May 20, 2022
0

The ongoing coronavirus disease-19 (COVID-19) pandemic, caused by a novel coronavirus, namely, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has...

Study: Persistence of endogenous SARS-CoV-2 and pepper mild mottle virus RNA in wastewater settled solids. Image Credit: NIAID

SARS-CoV-2 and pepper mild mottle virus RNA highly persistent in wastewater solids

by Medical Finance
May 20, 2022
0

A new study from the United States (US) investigates the persistence (lifetime) of viral ribonucleic acid (RNA) under different ambient...

Study: Effectiveness of mRNA-1273 against SARS-CoV-2 omicron and delta variants. Image Credit: Studio Romantic/Shutterstock

Evaluating effectiveness of the COVID-19 mRNA-1273 vaccine against Omicron and Delta variants

by Medical Finance
May 20, 2022
0

In a study recently published on the medRxiv* pre-print server, a team of researchers investigated the effectiveness of one to...

Study: Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts. Image Credit: Pormezz / Shutterstock

A common cold may boost the immune system against COVID-19

by Medical Finance
May 20, 2022
0

A recent groundbreaking research paper published in the journal Nature Communications reveals the association of circulating SARS-CoV-2-specific T cells at...

Study: Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures. Image Credit: SciePro / Shutterstock.com

Assessing how autoantibodies in COVID-19 correlate with anti-viral humoral responses

by Medical Finance
May 20, 2022
0

In a recent study published on the medRxiv* preprint server, a team of researchers screened several systemic autoantibodies to assess...

Next Post
Scientists unravel how blood cells mount the first line of defense against viruses

Genome research explains why oats could be suitable for most people with celiac disease

Swapping single food item for a more planet-friendly alternative could reduce diet’s carbon footprint

First large-scale estimate of live microbes consumed by Americans daily

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: A potent SARS-CoV-2 neutralizing antibody recognizing a conserved epitope with broad mutant variant and SARS-CoV activity. Image Credit: Design_Cells/Shutterstock
    Neutralizing antibody ABP-310 found to be highly potent against SARS-CoV-2 variants including Omicron
  • By Gorodenkoff 571684e159074a84992c0edbe24d0030 620x480
    PromoCell’s New GMP Certification – EXCiPACT
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply